BiotechTube
Home/Novakand Pharma/Thomas Olin
TO

Thomas Olin

Senior Scientific Advisor, Board Member

Novakand Pharma

Therapeutic Areas

Inflammatory DiseasesOncology

Novakand Pharma Pipeline

DrugIndicationPhase
RugocrixanInflammatory diseases / CancerClinical
FosrugocrixanInflammatory diseases / CancerClinical

Leadership Team at Novakand Pharma

PS
Peter Selin
CEO
EN
Erik Nerpin
Chairman of the Board
AG
Anders Gabrielsen
Board Member
View full Novakand Pharma profile